Teva Pharmaceutical Industries Ltd officer Mark Sabag sells $1.93M in stock

Mark Sabag, an officer of Teva Pharmaceutical Industries Ltd (TEVA), sold 46,000 shares on Nov 5 at an average price of $41.93, a total of about $1.9 million, according to a Form 4 filed with the SEC on Nov 6.

The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The trade was reported within two business days, as Section 16 requires.

The insider still holds 80,760 shares after the sale, 36% fewer than before.

The numbers below are taken from the Form 4 as filed with the SEC.

The sale

Company	Teva Pharmaceutical Industries Ltd (TEVA)
Insider	Mark Sabag
Role	Officer
Transaction	Open-market sale (code S)
Shares	46,000
Average price	$41.93
Value	$1,928,729
Trade date	Nov 5, 2026
Filed with the SEC	Nov 6, 2026, 4:03 PM ET
Shares held after	80,760
Ownership	Direct
Rule 10b5-1 plan	Not marked in the filing

View this Form 4 in Insider Stock Trader

View the Form 4 on SEC.gov

See more large insider sales · See the biggest insider trades of each day

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.